However, as with any medical intervention, there are important contraindications to consider
Moreover, we summarize the clinical manifestations, treatment, prognosis, and genetic characteristics of patients with GSSD reported in China to date
Non-use of validated assessment tools (e.g., stable 13C-labeled fatty acid breath test) and reliance on self-reported symptoms instead of validated GI disorder symptom indices are also limitations
Most research has been conducted in animal models, and the peptide is not currently FDA approved for medical use
Reconstituted aliquots are generally stored at 2-8C for short-term use
We will help you get by with an NAD+ injection